CDT Equity (CDT) notes the announcement issued by Sarborg regarding the filing of a U.S. provisional patent application relating to its proprietary AI Signature Agent. CDT holds a 20% equity stake in Sarborg and views this filing as an important step in strengthening and formalising Sarborg’s intellectual property position. Sarborg announced that a provisional patent application was filed with the United States Patent and Trademark Office on February 12, 2026, and has been assigned United States Patent Application No. 63/981,801. “As a 20% shareholder, we view the filing of Sarborg’s provisional patent application as an important milestone in the development and protection of its proprietary technology,” said Dr. Andrew Regan, Chief Executive of CDT. “We believe continued advancement of Sarborg’s intellectual property supports the scalability of its Signature Agent across multiple sectors and enhances its long-term growth profile.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDT:
- CDT Equity says advancing multiple initiatives to enhance shareholder value
- Conduit Pharmaceuticals Expands Stake Using Equity-Funded Acquisition Strategy
- CDT Equity notes Sarborg expansion into bacteria, agrochemicals
- CDT Equity entered into a transaction to acquire a 20% equity stake in Sarborg
- CDT Equity files to sell 22.85M shares of common stock for holders
